SCHEMBL2117124

SCHEMBL2117124

Nc1nc(C2OC[C@@H](O)[C@H]2O)nc2[nH]cnc12

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.34
ADORA3 P0DMS8 3/20 0.32
ADORA1 P30542 2/20 0.32
ADORA2B P29275 1/20 0.32
ADK P55263 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29383125 1.00 ADORA2A (0.34) ADORA2AADORA3ADORA1ADORA2BADK
SCHEMBL2983106 0.97 ADORA2A (0.34) ADORA2AADORA3ADORA1ADORA2BADK
SCHEMBL7638539 0.84
SCHEMBL7035571 0.82 PNP (0.31)
SCHEMBL2117131 0.79 PDPK1 (0.45) ADORA2AADORA1ADK
SCHEMBL2983115 0.76 PDPK1 (0.45) ADORA2AADORA1ADK
Water SCHEMBL27761338 0.75 PDPK1 (0.44) ADORA2AADORA1ADK
SCHEMBL5182595 0.74 HIF1A (0.43) ADORA2AADORA3ADORA1ADORA2B
SCHEMBL240028 0.74 HIF1A (0.43) ADORA2AADORA3ADORA1ADORA2B
SCHEMBL4436402 0.74 HIF1A (0.43) ADORA2AADORA3ADORA1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130030007-A1 Obesity Small Molecules AKRON MOLECULES GMBH (AT) 2013-01-31 US disclosed
EP-2521594-A2 OBESITY SMALL MOLECULES Akron Molecules GmbH (AT) 2012-11-14 EP disclosed
US-20120094947-A1 METHOD FOR THE SELECTIVE THERAPY OF DISEASE LUBIN ADAM (US) 2012-04-19 US disclosed
WO-2011083150-A2 OBESITY SMALL MOLECULES AKRON MOLECULES GMBH (AT) 2011-07-14 WO disclosed
EP-2192905-A2 METHOD FOR THE SELECTIVE THERAPY OF DISEASE Lubin, Adam (US) 2010-06-09 EP disclosed
WO-2009032057-A2 METHOD FOR THE SELECTIVE THERAPY OF DISEASE LUBIN ADAM (US) 2009-03-12 WO disclosed